The typhoid fever vaccines market is engaged in the manufacturing of vaccines to prevent typhoid infection caused by Salmonella Typhi bacteria. Typhoid fever is a life-threatening illness transmitted through contaminated food and water. The currently available typhoid fever vaccines include live attenuated oral Ty21a vaccine, Vi capsular polysaccharide vaccine, bivalent oral vaccine (Ty21a and Vi), and Vi conjugate vaccine. Growing disease burden, initiatives by governments and NGOs, and increasing awareness about vaccination are augmenting the demand for effective vaccination.
The Global typhoid fever vaccines market is estimated to be valued at US$ 454.2 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the typhoid fever vaccines market are Linde Plc, Air Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2 Energy
Growing disease burden is presenting lucrative opportunities for market players to develop new and more effective vaccines. Governments and international organizations are investing heavily in immunization programs in developing nations.
The typhoid fever disease predominantly affects Asia and Africa regions due to lack of clean drinking water and sanitation. Major players are focusing on expanding their manufacturing and distribution network in these high burden regions. Initiatives to improve sanitation and provide clean drinking water are complementing vaccination programs.
Market drivers
Increasing global disease burden of typhoid is a major growth driver for the Typhoid Fever Vaccines Market Demand. According to WHO estimates, over 11 million new cases and about 128,000 typhoid related deaths occur annually worldwide. Growing international travel and migration are facilitating cross-border spread of the disease. Government initiatives and recommendations to vaccinate high-risk population are expected to boost the adoption of typhoid vaccines.
PEST Analysis
Political: Government initiatives to promote vaccination drives and awareness campaigns positively impact the market. Some governments make vaccination mandatory which boosts demand.
Economic: As incomes rise, patients are able to afford vaccination drives. Better access to healthcare insurance further increases uptake.
Social: Increased health consciousness and availability of information drive patients towards preventive healthcare and vaccination.
Technological: Advancements in vaccine production technologies help expand capacities. Digital tools aid management of vaccination programs.
Geographical regions with high market concentration
The Asia Pacific region accounts for the major share of the global typhoid fever vaccines market in terms of value. This is attributed to high disease prevalence, large population sizes, government vaccination programs and improving access to healthcare in the region. Rising disposable incomes in developing countries also contribute to market growth.
Fastest growing region for the market
Africa is projected to be the fastest growing regional market during the forecast period. This is due to increasing investment towards relevant healthcare initiatives and vaccination drives by global organizations. Higher disease awareness creation along with economic and infrastructure development initiatives in the region support market expansion.
Get more insights on Typhoid Fever Vaccines Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
Comments
0 comment